<DOC>
	<DOCNO>NCT02424123</DOCNO>
	<brief_summary>Seizures represent important clinical problem , account least 40 % adult onset epilepsy . Predicting seizure recurrence subject experience first seizure difficult due lack prognostic biomarkers . Recent evidence indicate blood-brain barrier ( BBB ) dysfunction constitute etiological factor seizure . In particular , show modification BBB permeability associate seizure activity . In addition , demonstrate BBB permeability assess measure serum level protein S100B . Based data consideration investigator test whether extent BBB damage time first seizure predictive seizure recurrence . The main objective study evaluate association absolute ( ng/ml ) serum S100B level ( measure time first seizure ) experience , , seizure recurrence within one year follow-up .</brief_summary>
	<brief_title>Is Protein S100B Predictor First-to-chronic Seizure Conversion Adults ?</brief_title>
	<detailed_description>The secondary objective study investigate : A ) Prognostic capacity serum S100B level predict seizure recurrence . B ) Association variation ( % ) serum S100B level first seizure episode schedule follow-up ( D14-D28 ) seizure recurrence . C ) Correlation S100B IL-1b , IL-6 , NSE serum level time point . D ) Association serology data : ) EEG profile ( normal/abnormal ) ; b ) recurrence seizure ( Y/N ) . E ) Comparison S100B serum level lesional vs non-lesional patient . F ) Establishment bio-bank ( serum cell ) .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Protein S</mesh_term>
	<criteria>The patient correctly inform . The patient must give inform signed consent . The patient must insure beneficiary health insurance plan . The patient least ( â‰¥ ) 18 year old less ( &lt; ) 60 year old . The patient experience first generalize , epileptic seizure ( patient partial onset secondary generalization also include ) . The seizure occur less 24 hour ago . The patient participate another study may interfere result conclusion study . Within past three month , patient participate another study may interfere result conclusion study . The patient exclusion period determine previous study . The patient judicial protection . The patient refuse sign consent . It impossible correctly inform patient . The patient pregnant breastfeeding ( MRI contraindicate ) . Patient previous abnormal brain imaging ( MRI ) . Patient abnormal biological test toxicology ( alcohol , cocaine cannabis test ) , blood ionogram ( hyponatremia &lt; 130mM ) , liver enzymes ( &gt; 5N ) , inflammatory syndrome ( elevated Creactive protein ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>